Ethical Challenges and Lessons Learned During the Clinical Development of a Group A Meningococcal Conjugate Vaccine

Background. The group A meningococcal vaccine (PsA-TT) clinical development plan included clinical trials in India and in the West African region between 2005 and 2013. During this period, the Meningitis Vaccine Project (MVP) accumulated substantial experience in the ethical conduct of research to t...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Infect Dis
Autors principals: Martellet, Lionel, Sow, Samba O., Diallo, Aldiouma, Hodgson, Abraham, Kampmann, Beate, Hirve, Siddhivinayak, Tapia, Milagritos, Haidara, Fadima Cheick, Ndiaye, Assane, Diarra, Bou, Ansah, Patrick Odum, Akinsola, Adebayo, Idoko, Olubukola T., Adegbola, Richard A., Bavdekar, Ashish, Juvekar, Sanjay, Viviani, Simonetta, Enwere, Godwin C., Marchetti, Elisa, Chaumont, Julie, Makadi, Marie-Francoise, Pallardy, Flore, Kulkarni, Prasad S., Preziosi, Marie-Pierre, LaForce, F. Marc
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2015
Matèries:
The Meningitis Vaccine Project: The Development, Licensure, Introduction, and Impact of a New Group a Meningococcal Conjugate Vaccine for Africa
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4639500/
https://ncbi.nlm.nih.gov/pubmed/26553670
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/civ598
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars